Literature DB >> 12707125

An assessment of different filter systems for extracorporeal elimination of bivalirudin: an in vitro study.

Andreas Koster1, Derek Chew, Marcus Gründel, Harald Hausmann, Onnen Grauhan, Herman Kuppe, Bruce D Spiess.   

Abstract

IMPLICATIONS: Bivalirudin is a new, direct thrombin inhibitor. We investigated the extracorporeal elimination rate of different hemofilters and one plasmapheresis filter for bivalirudin. Our data show that bivalirudin can be effectively eliminated via hemofiltration and plasmapheresis, although there were significant differences in the elimination rates among the filter systems investigated.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12707125     DOI： 10.1213/01.ane.0000057605.61063.55

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


  8 in total

Review 1.  Direct thrombin inhibitors in cardiovascular disease.

Authors:  Kyle A Arsenault; Jack Hirsh; Richard P Whitlock; John W Eikelboom
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

2.  Anticoagulant therapy during cardiopulmonary bypass.

Authors:  Maryam Yavari; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2008-10-19       Impact factor: 2.300

Review 3.  Direct thrombin inhibitors: pharmacology and application in intensive care medicine.

Authors:  Eva Schaden; Sibylle A Kozek-Langenecker
Journal:  Intensive Care Med       Date:  2010-04-28       Impact factor: 17.440

Review 4.  The Use of Bivalirudin in Pediatric Cardiac Surgery and in the Interventional Cardiology Suite.

Authors:  Dheeraj Goswami; Matthew DiGiusto; Rajeev Wadia; Sean Barnes; Jamie Schwartz; Diana Steppan; Kristen Nelson-McMillan; Richard Ringel; Jochen Steppan
Journal:  J Cardiothorac Vasc Anesth       Date:  2020-01-21       Impact factor: 2.628

5.  Anticoagulation with bivalirudin during deep hypothermic circulatory arrest in a patient with heparin-induced thrombocytopenia.

Authors:  Agamemnon Pericleous; Mostafa Sadek; Mary Fitzmaurice; Constance Caldwell; Kris Natividad; Konstadinos A Plestis
Journal:  Tex Heart Inst J       Date:  2014-12-01

6.  Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement.

Authors:  Katie H Faella; David Whiting; Francis Fynn-Thompson; Gregory S Matte
Journal:  J Extra Corpor Technol       Date:  2016-03

Review 7.  [Direct thrombin inhibitors: pharmacology and application in cardiovascular anesthesia].

Authors:  S A Kozek-Langenecker
Journal:  Anaesthesist       Date:  2008-06       Impact factor: 1.041

8.  Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.

Authors:  G Galasso; M Mirra; G De Luca; F Piscione
Journal:  Transl Med UniSa       Date:  2016-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.